Voyageur Pharmaceuticals (VYYRF) Income Statement
Voyageur Pharmaceuticals Income Statement
Last quarter (Q2 2026), Voyageur Pharmaceuticals's total revenue was $16.28K. In Q2, Voyageur Pharmaceuticals's net income was $-996.99K. See Voyageur Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Feb 26 | Feb 25 | Feb 24 | Feb 23 | Feb 22 |
|---|---|---|---|---|---|
| $ 11.69K | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | |
| $ -1.22M | $ -1.57K | $ -2.19K | $ -2.91K | $ -2.25K | |
| $ 2.31M | $ 1.70M | $ 1.22M | $ 1.75M | $ 2.05M | |
| Depreciation and Amortization | $ 1.13K | $ 1.57K | $ 2.19K | $ 9.21K | $ 2.25K |
| $ -3.53M | $ -1.71M | $ -1.22M | $ -1.74M | $ -2.05M | |
| $ -3.53M | $ -1.70M | $ -1.22M | $ -1.75M | $ -2.05M | |
| $ 0.00 | $ -7.94K | $ -178.52K | $ -1.97K | $ -3.28K | |
| $ -3.53M | $ -1.71M | $ -1.40M | $ -1.75M | $ -2.05M | |
| $ -3.53M | $ -1.71M | $ -1.40M | $ -1.75M | $ -2.05M | |
| Per Share Metrics | |||||
| Basic EPS | $ -0.02 | $ -0.01 | $ -0.01 | $ -0.02 | $ -0.02 |
| Diluted EPS | $ -0.02 | $ -0.01 | $ -0.01 | $ -0.02 | $ -0.02 |
| Weighted Average Shares Outstanding | 165.66M | 137.63M | 130.50M | 107.83M | 94.68M |
| Weighted Average Shares Outstanding (Diluted) | 165.66M | 137.63M | 130.50M | 107.83M | 94.68M |
Currency in CAD
